Gillian Vandekerkhove, PhD, of the University of British Columbia, discusses her latest research on genomic testing in prostate cancer, including timing recommendations and a discussion on the role of interdisciplinary collaborations.
Dr. Vandekerkhove also explains how socioeconomic factors impact the utilization of genomic testing in prostate cancer diagnosis and treatment as well as the primary obstacles to standardizing the reporting in genomic testing.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.